Solid Biosciences Inc.SLDBNASDAQ
LOADING
|||
Switch Symbol:
EPS Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-14.29%
↑ 99% above average
Average (36q)
-2175.80%
Historical baseline
Range
High:99.75%
Low:-80817.43%
Volatility
-3719.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -14.29% |
| Q2 2025 | 28.81% |
| Q1 2025 | 26.25% |
| Q4 2024 | -1.27% |
| Q3 2024 | -29.51% |
| Q2 2024 | 4.69% |
| Q1 2024 | 8.57% |
| Q4 2023 | 33.33% |
| Q3 2023 | 16.00% |
| Q2 2023 | 18.83% |
| Q1 2023 | 18.52% |
| Q4 2022 | 30.26% |
| Q3 2022 | 17.88% |
| Q2 2022 | 2.08% |
| Q1 2022 | -33.20% |
| Q4 2021 | -5.42% |
| Q3 2021 | 5.88% |
| Q2 2021 | 10.53% |
| Q1 2021 | 37.22% |
| Q4 2020 | 31.21% |
| Q3 2020 | -12.82% |
| Q2 2020 | 30.36% |
| Q1 2020 | 15.66% |
| Q4 2019 | 0.90% |
| Q3 2019 | 11.84% |
| Q2 2019 | 10.59% |
| Q1 2019 | -34.35% |
| Q4 2018 | -15.03% |
| Q3 2018 | -5.77% |
| Q2 2018 | 3.70% |
| Q1 2018 | 28.32% |
| Q4 2017 | -7.31% |
| Q3 2017 | -19.39% |
| Q2 2017 | -80817.43% |
| Q1 2017 | 99.75% |
| Q4 2016 | 0.00% |
| Q1 2016 | 0.00% |